rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12 Mar ' 11
Sources of funds
Owner's fund
Equity share capital 17.68 17.67 11.80 11.80 11.80
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 768.65 518.65 344.48 260.04 203.75
Loan funds
Secured loans 40.22 101.05 107.70 148.23 126.93
Unsecured loans 9.95 10.77 15.76 14.00 31.35
Total 836.50 648.14 479.74 434.06 373.83
Uses of funds
Fixed assets
Gross block 493.97 433.31 403.11 348.48 290.34
Less : revaluation reserve - - - - -
Less : accumulated depreciation 222.65 171.91 140.38 111.92 84.15
Net block 271.32 261.40 262.73 236.56 206.19
Capital work-in-progress 170.20 93.55 12.49 2.51 17.22
Investments 76.62 78.84 18.86 17.05 17.05
Net current assets
Current assets, loans & advances 567.71 446.08 381.30 362.72 240.40
Less : current liabilities & provisions 249.35 231.73 195.64 184.79 107.02
Total net current assets 318.36 214.35 185.66 177.93 133.37
Miscellaneous expenses not written - - - - -
Total 836.50 648.14 479.74 434.06 373.83
Notes:
Book value of unquoted investments 17.12 23.84 18.86 17.05 17.05
Market value of quoted investments 65.24 56.98 - - -
Contingent liabilities 16.15 51.33 83.39 28.87 16.81
Number of equity sharesoutstanding (Lacs) 879.44 351.51 234.17 117.09 117.09
Close
Add Ajanta Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Ajanta Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close